These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors. Christopoulos A; Wilson K Brain Res; 2001 Oct; 915(1):70-8. PubMed ID: 11578621 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of antagonist and agonist binding to the human brain muscarinic receptor by arachidonic acid. Kjome JR; Swenson KA; Johnson MN; Bordayo EZ; Anderson LE; Klevan LC; Fraticelli AI; Aldrich SL; Fawcett JR; Venters HD; Ala TA; Frey WH J Mol Neurosci; 1998 Jun; 10(3):209-17. PubMed ID: 9770643 [TBL] [Abstract][Full Text] [Related]
4. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. De Petrocellis L; Melck D; Palmisano A; Bisogno T; Laezza C; Bifulco M; Di Marzo V Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8375-80. PubMed ID: 9653194 [TBL] [Abstract][Full Text] [Related]
5. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Bisogno T; MacCarrone M; De Petrocellis L; Jarrahian A; Finazzi-Agrò A; Hillard C; Di Marzo V Eur J Biochem; 2001 Apr; 268(7):1982-9. PubMed ID: 11277920 [TBL] [Abstract][Full Text] [Related]
6. Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. Butt C; Alptekin A; Shippenberg T; Oz M J Neurochem; 2008 May; 105(4):1235-43. PubMed ID: 18194436 [TBL] [Abstract][Full Text] [Related]
7. N-Morpholino- and N-diethyl-analogues of palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity. Vandevoorde S; Lambert DM; Smart D; Jonsson KO; Fowler CJ Bioorg Med Chem; 2003 Mar; 11(6):817-25. PubMed ID: 12614867 [TBL] [Abstract][Full Text] [Related]
8. A role for potassium channels in the regulation of cortical muscarinic acetylcholine receptors in an in vitro slice preparation. Shaw C; van Huizen F; Cynader MS; Wilkinson M Brain Res Mol Brain Res; 1989 Jan; 5(1):71-83. PubMed ID: 2538705 [TBL] [Abstract][Full Text] [Related]
10. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Roberts LA; Christie MJ; Connor M Br J Pharmacol; 2002 Oct; 137(4):421-8. PubMed ID: 12359623 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors. Mang CF; Erbelding D; Kilbinger H Br J Pharmacol; 2001 Sep; 134(1):161-7. PubMed ID: 11522608 [TBL] [Abstract][Full Text] [Related]
12. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624 [TBL] [Abstract][Full Text] [Related]
14. Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides. Barg J; Fride E; Hanus L; Levy R; Matus-Leibovitch N; Heldman E; Bayewitch M; Mechoulam R; Vogel Z Eur J Pharmacol; 1995 Dec; 287(2):145-52. PubMed ID: 8749028 [TBL] [Abstract][Full Text] [Related]
15. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899 [TBL] [Abstract][Full Text] [Related]
16. The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism. Oz M; Jaligam V; Galadari S; Petroianu G; Shuba YM; Shippenberg TS J Neurochem; 2010 Mar; 112(6):1454-64. PubMed ID: 20050977 [TBL] [Abstract][Full Text] [Related]
17. Endogenous cannabinoid anandamide directly inhibits voltage-dependent Ca(2+) fluxes in rabbit T-tubule membranes. Oz M; Tchugunova YB; Dunn SM Eur J Pharmacol; 2000 Sep; 404(1-2):13-20. PubMed ID: 10980258 [TBL] [Abstract][Full Text] [Related]
18. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. White R; Hiley CR Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801 [TBL] [Abstract][Full Text] [Related]
19. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons. Fisyunov A; Tsintsadze V; Min R; Burnashev N; Lozovaya N J Neurophysiol; 2006 Sep; 96(3):1267-77. PubMed ID: 16738209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]